Synonym: (±)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid; AA-2414
CAS Number: 112665-43-7
Empirical Formula (Hill Notation): C22H26O4
Molecular Weight: 354.44
MDL Number: MFCD00875701
Linear Formula: C22H26O4
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML1379-10MG.
| assay |
≥98% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24) |
| InChI key |
ZBVKEHDGYSLCCC-UHFFFAOYSA-N |
| Quality Level |
100  |
| SMILES string |
O=C(C(C)=C1C)C(C)=C(C(CCCCCC(O)=O)C2=CC=CC=C2)C1=O |
| solubility |
DMSO: 25 mg/mL, clear |
| storage temp. |
2-8°C |
| Biochem/physiol Actions: |
Seratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist with anti-asthmatic activity. |
| Biochem/physiol Actions: |
Seratrodast is a thromboxane A2 (TXA2) receptor (TP receptor) antagonist with anti-asthmatic activity. Seratrodast inhibits the bronchconstriction induced by leukotriene D4 (LTD4), and platelet activating factor (PAF) with a long duration of action. |
| Packaging: |
10, 50 mg in glass bottle |
| Symbol |
GHS08 |
| Signal word |
Warning |
| Hazard statements |
H361d |
| Precautionary statements |
P201 - P308 + P313 |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
51111800 |